Support Groups with Filters
Clinical Trial Testing Effectiveness of Blood Cancer Drug in Recurrent Glioblastoma
**Sponsored Content**
Learn more about Biodexa’s Phase 1 clinical trial investigating the effectiveness of an approved blood cancer drug in liquid form to treat recurrent glioblastoma (GBM).
Study to Evaluate the Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBl-1901 in Recurrent GBM Subjects
Study to Evaluate the Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBl-1901 in Recurrent GBM Subjects Featured Clinical Study Study to Evaluate the Safety, Tolerability, and Optimal Dose
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM (FRONTIER)
Featured Clinical Study A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM (FRONTIER) Study Sponsor: Boston Scientific Study website: Frontier Study
Cancer Support Community of Greater Ann Arbor Brain Tumor Support Group
Contact Person Taylor Fischman, LMSW 734-975-2500 Info@cancersupportannarbor.org Location Virtual Web Address Date and Time 2nd Thursday of every month 6:00 p.m. – 7:30 p.m. ET If you or a loved
ABTA Announces $1.3 Million in New Funding to Accelerate Adult and Pediatric Brain Tumor Research
The American Brain Tumor Association (ABTA) today announced the funding of $1.37 million towards 23 new research grants to advance brain tumor science and treatments, across all brain tumor types and ages. Dedicated to advancing the field of neuro-oncology and accelerating the discovery of life-saving treatments, the ABTA is proud to have invested more than $35 million, to approximately 700 researchers to support 800 projects, to date.
Your Support Turns Hope Into Action
Join us in our mission to accelerate research breakthroughs and fuel hope for brain tumor patients and families.